Dean Koh

Founded in 2016, Theranica, a biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, yesterday announced the closing of its round B of financing, of $35M, led by aMoon, Israel's largest healthcare VC.

Yesterday, Singapore-based health technology startup CXA Group, which offers an employee benefits and wellness marketplace platform, announced that it has raised $25 million in its latest round of funding.

Gojek an Indonesia-headquartered ride-hailing and logistics company with operations in Indonesia, Vietnam, Singapore and Thailand, today announced that it has partnered with Singapore-based startup Doctor Anywhere, to offer offline and online medical consultations to its drivers.

Health2Sync and Novo Nordisk Pharma Ltd.

Halodoc, an Indonesia-based health-tech platform, recently announced that it has raised $65M in a series B funding led by new investor UOB Venture Management.

China’s one-stop healthcare ecosystem platform, Ping An Good Doctor, yesterday announced its first annual results since listing: the company recorded a revenue of RMB 3.

The Singapore University of Social Sciences (SUSS) signed a Memorandum of Understanding (MOU) on February 23 with Changi General Hospital Pte Ltd (CGH) and SingHealth Community Hospitals (SCH) to collaborate on various initiatives to better understand and support the needs of the growing silver generation as well as their caregivers.

BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development.

Beijing-headquartered clinical genomics testing company, Berry Genomics and Hong Kong and London-headquartered genetics and digital health company Prenetics announced today key management hires for the new company, Circle DNA, which will be operational for business by the end of Q2 2019.

Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million.